speb/financial-data huggingface dataset:
RELAXO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3835000000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 52100000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 52100000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 5938100000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 21124600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2271000000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1660600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1660600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 232100000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 16400000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -52100000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -52100000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 14004600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 20992600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 195500000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 934200000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 361600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 418000000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 6285400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 659200000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 700900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 20846000000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 102300000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 439900000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 122600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2022900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 13258200000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2536000000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2683200000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 488500000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2450400000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 393600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 21094900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 20992600000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 126900000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 28701500000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 21094900000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2154700000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 21094900000.00
RELAXO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 5867400000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7606600000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 16818000000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2088200000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 98200000.00
RELAXO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 6365100000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3541300000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 6680300000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 250377358.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.06
RELAXO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2836500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 391400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 391400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 250377358.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.06
RELAXO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — EBIT: 412100000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 803500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 3843800000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 52900000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 52900000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -52900000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -52900000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 803500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 265400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 302500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 6680300000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 109600000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2047500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 359200000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2836500000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 391400000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 93800000.00
RELAXO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
RELAXO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 6377800000.00
RELAXO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 13823500000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3415800000.00
RELAXO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 27021600000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 7511000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2626400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2626400000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2988900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2988900000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 2682400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 2682400000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 248786765.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.72
RELAXO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 223700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1371200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 2326500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2326500000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 248900000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 176900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 176900000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2284200000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2284200000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -746800000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -41800000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -589600000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 19900000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Payable: 674200000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 105400000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 295300000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -47000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 248900000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 22063600000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 22063600000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 967000000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 967000000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 11030300000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3245900000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 11935200000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 11935200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 449800000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 449800000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 449800000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 449800000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 5126300000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5126300000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 510300000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 510300000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Depreciation: 1572000000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1572000000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1572000000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 390500000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1572000000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 390500000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 248786765.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.72
RELAXO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — EBIT: 2629800000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — EBIT: 965900000.00
RELAXO.NS income_statement (annual, 2026-03-31) — EBITDA: 4201800000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1356400000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 200000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 176900000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -1464300000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 2111300000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -67700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 3000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 88500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 88500000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 14530700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 14530700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Gross Profit: 15991300000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 4265100000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Interest Expense: 215200000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 58100000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 215200000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 58100000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -215200000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 147600000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Inventory: 5567200000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 5567200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 22063600000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 22063600000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2065200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 2682400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2682400000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 1876700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1876700000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1876700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1876700000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 211900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 211900000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -17800000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income: 676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 676700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2414600000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 676700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -6500000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -215200000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -58100000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -855600000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
RELAXO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -215200000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -58100000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 14530700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 14530700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1350700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 0.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 21975100000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 21975100000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 210900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 210900000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 4201800000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1356400000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Normalized Income: 1792700000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 676700000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 3482500000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Operating Income: 2167800000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Operating Income: 849300000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 27021600000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 7511000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 248938586.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1091400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1091400000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 632800000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 632800000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 21814700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 21814700000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 88500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 88500000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -160000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 252400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 252400000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 462000000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 116600000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 8133400000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2065200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 13563700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 13563700000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 3500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3500000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2107300000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2107300000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Payables: 2676700000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2676700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Pretax Income: 2414600000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 907800000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -6500000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1364700000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 11030300000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3245900000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1572000000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 390500000.00
RELAXO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 14000000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 248938586.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 248938586.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 22063600000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 22063600000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 21975100000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 21975100000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RELAXO.NS income_statement (annual, 2026-03-31) — Tax Provision: 621900000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 231100000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
RELAXO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
RELAXO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -667300000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 29489400000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 29489400000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 22063600000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 22063600000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2326500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2326500000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 22063600000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 22063600000.00
RELAXO.NS income_statement (annual, 2026-03-31) — Total Expenses: 24853800000.00
RELAXO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 6661700000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 7425800000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7425800000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 17554200000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 17554200000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2299500000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2299500000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 50300000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 50300000.00
RELAXO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 6808900000.00
RELAXO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 6808900000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1251700000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — +Total Revenue: 3474277000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 276053000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 54343000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -314729000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 256196000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -3650000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 13790000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Basic EPS: 24.04
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 3192000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 452128000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -520395000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 32198000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 686000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 576116000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -15087000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 686000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Inventory: 22282000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -109831000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 109787000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Payable: 106018000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Receivables: 52322000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 181774000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -2506000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -15087000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1214238000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 101520000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 1869695000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Current Assets: 1308827000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 8592000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Current Debt: 776919000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 785511000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 1342817000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Depreciation: 85298000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 85298000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 85298000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 85298000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Diluted EPS: 24.04
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 181322000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 1888000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — EBIT: 353538000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — EBITDA: 438836000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — End Cash Position: 686000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 139311000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 188370000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 73291000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 27497000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 6474000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 6318000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 540000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 57993000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 2204522000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Gross Profit: 1604582000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Interest Expense: 80025000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 80025000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Interest Income: 26448000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 26448000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -121192000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 24758000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Inventory: 444433000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 2461662000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -735503000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 20333000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 13790000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 284227000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 392987000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 23606000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 470505000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 494111000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 131900000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 4929000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1257887000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Net Debt: 1246738000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income: 181322000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 181322000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 181323000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 181322000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 181322000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 273513000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 181323000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Interest Income: -95037000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -253241000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 284227000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 131900000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -95037000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -254958000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Net PPE: 1889793000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -507020000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 152327000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1213698000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 250157000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4929000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 98770000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 469105000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Normalized Income: 209466116.20
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 593686000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Operating Income: 352882000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Operating Revenue: 3474277000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 162147000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 107063000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 1138641000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 540000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 399000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 91792000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 52695000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: -1000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 3963000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 363428000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Payable: 163705000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Properties: 1788273000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 56919000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 575430000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Other Special Charges: 2772000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Payables: 441646000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8597000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 175128000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Pretax Income: 273513000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -31603000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -254958000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -520395000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 143760000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 1869695000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 85298000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 1655000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1655000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 1888000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 817966000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 1717000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 13375000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 414215000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 420533000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 152327000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Special Income Charges: -2772000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1214238000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1213698000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -2124883.80
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Tax Provision: 92190000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.07
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 5623000.00
RELCHEMQ.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -40624000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Assets: 3332051000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 1684743000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Debt: 1279622000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 1214238000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Total Expenses: 3121395000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2117813000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2023226000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 774996000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 41460000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -30269000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -30269000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 24198000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Work In Process: 111904000.00
RELCHEMQ.NS balance_sheet (annual, 2022-03-31) — Working Capital: -33990000.00
RELCHEMQ.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1294643000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — +Total Revenue: 3580517000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 143723000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 74056000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -388407000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 256196000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -845000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 195000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 8791000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Basic EPS: 16.46
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 686000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 462534000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -545738000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 30905000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 40436000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 613149000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -18859000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 40436000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -8263000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -119057000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -69596000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Payable: -109449000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -16908000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -322743000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 39750000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1320071000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 389388000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 2000544000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1461329000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 8172000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1298568000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1306740000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1654403000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 9298000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Depreciation: 97374000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 97569000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 97569000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 97569000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Diluted EPS: 16.46
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 124192000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2247000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — EBIT: 252296000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — EBITDA: 349865000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — End Cash Position: 40436000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 546908000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 145992000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -546125000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -2002000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 4692000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 6747000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4338000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 74901000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2712787000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Gross Profit: 1579973000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Interest Expense: 85221000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 85221000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Interest Income: 30763000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 30763000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -137317000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 31148000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Inventory: 452696000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 3282624000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -506771000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 19963000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 8791000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 715130000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 386478000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 22733000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 663985000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 686718000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 193480000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 4759000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1474387000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1922117000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income: 124192000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 124192000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 124192000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 124192000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 124192000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 167075000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 124192000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Interest Income: -108555000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 2358000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 715130000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 193480000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -108555000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2324380000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -540277000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 521650000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1315733000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 277171000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4759000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 150808000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 350536000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Normalized Income: 124690774.99
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -387000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Operating Income: 285330000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Operating Revenue: 3580517000.00